Evidence map›Paper›PMID 35933574›Full record

ArticleHead and neck pathology2022

GLI1-Altered Soft Tissue Tumors of the Head and Neck: Frequent Oropharyngeal Involvement, p16 Immunoreactivity, and Detectable Alterations by DDIT3 Break Apart FISH.

Doreen N Palsgrove, Lisa M Rooper, Todd M Stevens, Christina Shin, Douglas D Damm, Jeffrey Gagan, Julia A Bridge, Lester D R Thompson, Prasad R Koduru, Justin A Bishop

Open access · greenAbstract read
In one paragraph

Article in Head and neck pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cells · 2025
    Review
  6. Review
  7. GLI1-altered mesenchymal tumor of tongue: a case report and literature review.Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2024
    Review
  8. Article
  9. GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2024
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 2 countries.

Doreen N PalsgroveDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA. doreen.palsgrove@utsouthwestern.edu.ORCID http://orcid.org/0000-0001-9640-2482
Lisa M RooperDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Todd M StevensDepartment of Pathology, University of Kansas Medical Center, Kansas City, KS, USA.
Christina ShinHistopathology Department, Middlemore Hospital, Auckland, New Zealand.
Douglas D DammPathology and Cytology Laboratories, Lexington, KY, USA.
Jeffrey GaganDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Julia A BridgeProPath, Dallas, TX, USA.
Lester D R ThompsonHead and Neck Pathology Consultations, Woodland Hills, CA, USA.
Prasad R KoduruDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Justin A BishopDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
The University of Texas Southwestern Medical Center · USExperimental Pathology Laboratories · USJohns Hopkins University · USMiddlemore Hospital · NZPropath Services (United States) · USSouthwestern Medical Center · USUniversity of Kansas Medical Center · USWoodland Hills Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGLI1 is a transcription factor protein that has recently gained recognition in a morphologically distinct group of epithelioid soft tissue tumors characterized by GLI1 fusions or amplifications. The head and neck region, particularly the tongue, is a common location for GLI1-altered tumors. DDIT3 break apart fluorescence in situ hybridization (FISH), commonly used to identify translocations in myxoid/round cell liposarcoma, has been used as a surrogate test to detect both fusions and amplifications of the 12q13.3 region encompassing DDIT3 and GLI1 gene loci.

methodsWe herein report 5 cases of GLI1-altered soft tissue tumors. Three arose in the oropharynx (base of tongue/vallecula, tonsil) and two arose in the tongue. Given the frequent oropharyngeal location and epithelioid morphology, p16 immunohistochemistry was performed on cases with available material. Commercially available DDIT3 break apart FISH, custom GLI1 specific FISH, and RNA sequencing were performed on select cases.

resultsTwo cases showed amplification using DDIT3 FISH which was confirmed using GLI1 specific FISH. The remaining cases harbored ACTB::GLI1, one of which showed rearrangement of the 12q13.3 region by DDIT3 FISH with absence of amplification by GLI1 specific FISH. STAT6 immunoexpression was positive in the GLI1-amplified cases and negative in the GLI1-rearranged cases while MDM2 expression was positive in the 4 cases tested. CDK4 expression was strong and diffuse in the GLI1-amplified cases. p16 immunohistochemistry showed strong nuclear and cytoplasmic staining in 50-70% of tumor cells in all four tested cases.

conclusionHere we show that GLI1-altered soft tissue tumors are frequently positive for p16 and can occur in tonsillar regions of the oropharynx. As such, positive p16 immunohistochemistry alone cannot be used as evidence for the diagnosis of HPV-related squamous cell carcinoma as strong and diffuse p16 expression may also occur in GLI1-altered soft tissue tumors. Commercially available DDIT3 break apart FISH, which is readily available in many cytogenetic laboratories, may be useful as a sensitive surrogate test for GLI1 fusions and amplifications.

Indexed as

Head and Neck NeoplasmsSoft Tissue NeoplasmsAdultHumansIn Situ Hybridization, FluorescenceTranscription Factor CHOPZinc Finger Protein GLI1DDIT3 protein, humanGLI1 protein, humanTranscription Factor CHOPZinc Finger Protein GLI1DDIT3FISHGLI1Oropharynxp16

Identifiers

PMID35933574
PMCPMC9729462
OpenAlexW4290091131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.